Cases 71 - 80 of 133
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al
as 1:2018cv01043
Defendant:
Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant:
Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
CELGENE CORPORATION v. ANNORA PHARMA PRIVATE LIMITED et al
as 3:2018cv11220
Defendant:
HETERO USA INC. and ANNORA PHARMA PRIVATE LIMITED
Plaintiff:
CELGENE CORPORATION
Cause Of Action: 15 U.S.C. § 1126
BIAL - PORTELA & CA S.A. et al v. Hetero Labs Limited et al
as 1:2018cv00342
Plaintiff:
BIAL - PORTELA & CA S.A. , Bial - Holding, S.A. and Sunovion Pharmaceuticals Inc.
Defendant:
Hetero Labs Limited , Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271
H. Lundbeck A/S et al v. Hetero USA Inc. et al
as 1:2018cv00176
Plaintiff:
H. Lundbeck A/S , Takeda Pharmaceutical Company Ltd. , Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant:
Hetero USA Inc. , Hetero Labs Limited and Hetero Labs Limited Unit-V
Cause Of Action: 35 U.S.C. § 271
H. Lundbeck A/S et al v. Lupin Limited, et al
as 1:2018cv00088
Counter Defendant:
Takeda Pharmaceutical Company Ltd.
Plaintiff:
Takeda Pharmaceuticals International AG, H. Lundbeck A/S, Takeda Pharmaceuticals U.S.A., Inc. and others
Defendant:
Apotex Inc., Apotex Research Private Limited, Apotex Corp. and others
Counter Claimant:
Unichem Laboratories, Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. et al v. HETERO USA INC. et al
as 3:2017cv07923
Plaintiff:
BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. and BOEHRINGER INGELHEIM INTERNATIONAL GMBH
Defendant:
HETERO USA INC., HETERO LABS LIMITED UNIT-V and HETERO LABS LIMITED
Cause Of Action: 15 U.S.C. § 1126
Takeda Pharmaceuticals U.S.A., Inc. v. Hetero Labs Limited et al
as 1:2017cv01020
Plaintiff:
Takeda Pharmaceuticals U.S.A., Inc.
Defendant:
Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc.
Cause Of Action: 35 U.S.C. § 271
MITSUBISHI TANABE PHARMA CORPORATION et al v. PRINSTON PHARMACEUTICAL, INC. et al
as 3:2017cv05135
Plaintiff:
MITSUBISHI TANABE PHARMA CORPORATION , JANSSEN PHARMACEUTICALS, INC. , JANSSEN PHARMACEUTICA NV and others
Defendant:
PRINSTON PHARMACEUTICAL, INC., DR. REDDY'S LABORATORIES, INC., DR. REDDY'S LABORATORIES, LTD. and others
Cause Of Action: 15 U.S.C. § 1126
Biogen International GmbH et al v. Hetero USA Inc. et al
as 1:2017cv00825
Plaintiff:
Biogen International GmbH and Biogen MA Inc.
Defendant:
Hetero USA Inc. , Hetero Labs Limited Unit-III and Hetero Labs Limited
Cause Of Action: 35 U.S.C. § 271
Biogen International GmbH et al v. Amneal Pharmaceuticals LLC et al.
as 1:2017cv00823
Defendant:
TWi Pharmaceuticals Inc., Amneal Pharmaceuticals LLC, Sawai Pharmaceutical Co., Ltd. and others
Plaintiff:
Biogen International GmbH and Biogen MA Inc.
Cause Of Action: 35 U.S.C. § 271
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
